With the Biden administration set to roll out its COVID-19 vaccination booster plan next week, a U.S. Food and Drug Administration (FDA) advisory panel today (September 17, 2021) voted 16-2 to reject one of Pfizer's booster vaccine in people ages 16 and older, according to the WND website.
The panel said there is insufficient data to judge the risks to younger groups, including the possible increased risk for heart inflammation, particularly among males ages 16-17.
A new study from the University of California at Davis found that teenage boys are six times more likely to suffer from heart problems from vaccine than be hospitalized from COVID-19.
No comments:
Post a Comment